Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Animal models indicate that the antimicrobial peptide hepcidin (HAMP; OMIM 606464) is probably a key regulator of iron absorption in mammals. Here we report the identification of two mutations (93delG and 166C-->T) in HAMP on 19q13 in two families with a new type of juvenile hemochromatosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficits in hepcidin-mediated regulation of FPN, often due to hereditary hemochromatoses, lead to iron overload and widespread tissue damage affecting the liver, heart, pancreas, and joints 11-13 .”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [11]
In the citing paper
“There is a single human hepcidin gene whose essential role in iron homeostasis was confirmed by identifying homozygous frameshift or nonsense mutations in affected individuals with severe juvenile hemochromatosis”
From IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin (2004) · cites this paper as [9]
In the citing paper
“HAMP‐deficient mice and humans present with a severe iron loading phenotype, and injection of synthetic HAMP decreases serum iron concentrations. 39 , 40 , 41”
From The battle for iron in enteric infections (2020) · cites this paper as [40]
In the citing paper
“First, mutations in the hepcidin gene itself (called HAMP) cause hemochromatosis by preventing the production of functional hepcidin protein.161”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [161]
In the citing paper
“In iron-replete cells, IRP1, which has ∼30% homology to mitochondrial aconitase based on amino acid alignments, loses its affinity for the IRE, and converts to a cytosolic aconitase (127, 263).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [263]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Self-citationWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13468 · Cited by 561
Autosomal-dominant hemochrom-atosis is associated with a mutation in the ferroportin (SLC11A3) gene
Montosi, G., Donovan, A., Totaro, A., Garuti, C., Pignatti, E., Cassanelli, S., Trenor, C. C., Gasparini, P., Andrews, N. C., & Pietrangelo, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113468 · Cited by 557
Cited by
Items 601–700 of 869
[Progress on epigenetic regulation of iron homeostasis].
Duan, L., Yin, X., Meng, H., Fang, X., Min, J., & Wang, F. (2020) · PubMed · doi:10.3785/j.issn.1008-9292.2020.02.25 · Cited by 13
Wu, H., Zhang, J., Fu, L., Wu, R., Gu, Z., Yin, C., & He, K. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221147772 · Cited by 9
“HAMP, involved in the maintenance of iron homeostasis and played a vital role in iron absorption regulation.(22) HAMP was up-regulated and responsible for the progression of colorectal adenocarcinoma tissue iron metabolism.”
BackgroundZhabyeyev, P., Sadasivan, C., Shah, S., Wang, F., & Oudit, G. Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129349 · Cited by 9
“Mutations in Hjv (Hfe2) gene are considerably less frequent but lead to juvenile hemochromatosis with a high degree of iron overload and overt cardiac phenotype (7, 9).”
BackgroundRegulatory variation in hepcidin expression as a heritable quantitative trait
Bayele, H. K., & Srai, S. K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.032 · Cited by 11
Case 21-2005: A Four-Week-Old Male Infant with Jaundice and Thrombocytopenia
Andrews, N. C., Anupindi, S. A., & Badizadegan, K. (2005) · New England Journal of Medicine · doi:10.1056/nejmcpc059016 · Cited by 9
Paterson, A. C., & Pietrangelo, A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00005-2 · Cited by 9
Schranz, M., Talasz, H., Graziadei, I. W., Winder, T. L., Sergi, C. M., Bogner, K., Vogel, W., & Zoller, H. (2009) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e31817cfd4b · Cited by 9
“genetic variants of the HAMP have been reported.(18) Clinically apparent iron overload in patients above 20 years of age has been described in association with mutations in the gene encoding transferrin receptor 2, which spans 18 exons and a coding region of B3 kb, limiting its analysis to dedicated laboratories.”
BackgroundWheeler, C. J., & Kowdley, K. V. (2006) · Comprehensive Therapy · doi:10.1385/comp:32:1:10 · Cited by 10
““Type 2,” or juvenile hemochromatosis, has been associated with mutations in the hemojuvelin (HJV) and hepcidin (HAMP) genes ( 11 ,14).”
BackgroundCongenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two cases
Hovinga, J. A. K., Solenthaler, M., & Dufour, J. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200310000-00014 · Cited by 9
Ripley, D. A., Morris, R. H., & Maddocks, S. E. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12553 · Cited by 8
“…levels that are persistently increased in conditions such as chronic infection or inflammation can lead to iron redistribution into the reticuloendothelial system, causing anaemia due to the reduced supply of iron to the bone marrow for erythropoiesis (Nicolas et al., 2001; Roetto et al., 2003).”
BackgroundJuvenile Hereditary Hemochromatosis
Goldberg, Y. P. (2011) · Cited by 9
Low ceruloplasmin levels exacerbate retinal degeneration in a hereditary hemochromatosis model
Anderson, B. D., Lee, T. T., Bell, B. A., Song, Y., & Dunaief, J. L. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050226 · Cited by 8
“Mutations in HEPC , FPN or HFE can lead to HH, in part by allowing unfettered iron import from the basolateral membrane of gut enterocytes into the bloodstream (Montosi et al., 2001; Roetto et al., 2003).”
Phlebotomy or bloodletting: from tradition to evidence‐based medicine
Jhang, J. S., & Schwartz, J. E. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03548.x · Cited by 8
Mansion, F., Chiap, P., Houbart, V., Crommen, J., Servais, A., & Fillet, M. (2011) · Journal of Separation Science · doi:10.1002/jssc.201100244 · Cited by 8
Iron Metabolism in Humans: An Overview
Arora, S., & Kapoor, R. (2012) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/39031 · Cited by 12
“The development of iron overload in hepcidin knockout mice [40] and humans with mutations in the hepcidin gene [55] is clearly explicable by the effects of hepcidin on intestinal iron absorption.”
Iron metabolism in macrophages from HFE hemochromatosis patients
Jacolot, S., Yang, Y., Paitry, P., Férec, C., & Mura, C. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.07.010 · Cited by 9
Hereditary Hemochromatosis-Special Reference to Indian Scenario
Poddar, S. (2006) · International Journal of Human Genetics · doi:10.1080/09723757.2006.11885947 · Cited by 8
“Pathological mutations have been discovered in 5 genes: HFE (encoding HFE), TFR2 (encoding transferrin receptor-2), SLC40A1(encoding ferroportin), HAMP (encoding hepcidin) and HJV (encoding hemojuvelin) (Feder et al. 1996; Camaschella 2000; Montosi et al. 2001; Njajou et al. 2001; Roetto et al. 2003; Papanikolaou et a…”
New HJV Mutation in a Patient with Hyperferritinemia and H63D Homozygosity for the HFE Gene
de Diego, C., Opazo, S., Sánchez-Castaño, Á., & Martínez‐Castro, P. (2007) · International Journal of Hematology · doi:10.1532/ijh97.e0748 · Cited by 8
“Four other genes have been described as causing hemochromatosis: TFR2 [2], FPN1 [3] (autosomal dominant inheritance), HAMP [ 4 ], and HJV [5].”
BackgroundHepcidina, una nueva proteína en la homeostasis del hierro
Rueda, A. D. C., & Álvarez, J. D. P. (2003) · Anales de Medicina Interna · doi:10.4321/s0212-71992003001200001 · Cited by 12
Characteristics of HFE C282Y Homozygotes Younger than Age 30 Years
Barton, J. C., Felitti, V. J., Lee, P. L., & Beutler, E. (2004) · Acta Haematologica · doi:10.1159/000081277 · Cited by 8
Zehra, A., Abdullah, S. M., Saboor, M., & Moinuddin (2016) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-016-0736-1 · Cited by 8
Appropriate Clinical Genetic Testing of Hemochromatosis Type 2–4, Including Ferroportin Disease
Kowdley, D. S., & Kowdley, K. V. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s269622 · Cited by 7
“R56X).(60) This led HAMP-associated HH to be classified as a subtype of JH.”
BackgroundTransferrin receptor 2 is emerging as a major player in the control of iron metabolism
Calzolari, A., Oliviero, I., & Testa, U. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0007-0 · Cited by 7
“Mice lacking hepcidin expression and humans with mutations in the hepcidin gene have been found to develop severe iron overload at an early age (juvenile hemochromatosis) [24, 25].”
BackgroundNew hope for treatment of neonatal haemochromatosis
Gissen, P., & Kelly, D. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17367-4 · Cited by 7
Physiopathologie et génétique de l'hémochromatose HFE de type 1
Loréal, O., Ropert, M., Mosser, A., Déhais, V., Deugnier, Y., David, V., Brissot, P., & Jouanolle, A. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2007.03.038 · Cited by 7
Eisen als Komorbidit�tsfaktor der chronischen Hepatitis C*
Erhardt, A., Hauck, K., & H�ussinger, D. (2003) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-003-1314-5 · Cited by 7
Development of rat and mouse models of heme-iron absorption
Lee, J. K., He, Y., Flores, S. R., Woloshun, R. R., Wang, X., Shine, J. S., Ebea, P. O., Sriram, S., Fraga, M., Zhu, S., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.184742 · Cited by 7
“Mutations in HAMP , encoding hepcidin, underlie a rare, severe early-onset form of the disease (43, 44).”
Flores, S. R., Nelson, S., Woloshun, R. R., Wang, X., Ha, J., Lee, J. K., Yu, Y., Merlin, D., & Collins, J. F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252998 · Cited by 6
“We chose to model type 2B HH (due to mutations in Hamp), which is a very rare, early onset form of the human disease [38], since we postulated that observations made in this more severe HH model would also be informative in relation to other (less severe) forms of the disease.”
BackgroundMethodSingh, M. K., Ashwell, M., Sanderson, P., Cade, J. E., Moreton, J. A., Fairweather‐Tait, S. J., Roe, M. A., Marx, J. J. M., Worwood, M., & Cook, J. D. (2006) · PubMed · doi:10.1079/bjn20061892 · Cited by 7
“In a minority of cases, there may be mutations in the genes encoding transferrin receptor 2, ferroportin-1, haemojuvelin and hepcidin (Roetto et al. 2003; Swinkels et al. 2006).”
BackgroundWei, L., Xiu, S. W., Tang, F., Li, P., & Du, L. C. (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb10.745 · Cited by 6
“Further studies showed that hepcidin gene expression was up-regulated under iron-overloaded conditions and the hepcidin gene knockout of mouse led to hepatic iron accumulation, however, in humans, it leads to hereditary hemochromatosis (Nicolas et al., 2001; Roetto et al., 2003).”
BackgroundProtein Susceptibility to Peroxidation by 4-Hydroxynonenal in Hereditary Hemochromatosis
Sánchez-Jaut, S., Pérez-Benavente, S., Abad, P., Méndez-Cuadro, D., Puyet, A., Díez, A., Galicia‐Poblet, G., Gómez-Domínguez, E., Morán‐Jiménez, M., Bautista, J. M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032922 · Cited by 6
“Some other rare forms involve genes encoding hemojuvelin (HJV) [1], hepcidin (HAMP) [2], transferrin receptor 2 (TFR2) [3] and ferroportin (SLC40A1) [4].”
Backgroundshawkat, E., Abdulrahman, S., & Bakr, B. A. (2023) · Kirkuk journal of science · doi:10.32894/kujss.2023.141071.1104 · Cited by 6
“It is possible to measure the glomerular filtration rate by calculating creatinine clearance [13].”
MethodHino, K., & Harada, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55790-6_7 · Cited by 6
Iron chelation for the treatment of uveitis
Chen, J., Zhou, J., Kelly, M. E. M., Holbein, B. E., & Lehmann, C. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.03.029 · Cited by 6
New insights into intestinal iron absorption
Hörl, W. H. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn458 · Cited by 8
“Mice with constitutive over-expression of hepcidin die from severe iron-deficient anaemia [11], while mutations in the hepcidin gene result in a severe form of juvenile haemochromatosis [12].”
BackgroundRosenberg, W. M. (2007) · Medicine · doi:10.1016/j.mpmed.2006.11.014 · Cited by 6
Eckmann, L. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50045-3 · Cited by 7
Sex and Gender Differences in Iron Chelation
Allegra, S., Comità, S., Roetto, A., & Francia, S. D. (2024) · Biomedicines · doi:10.3390/biomedicines12122885 · Cited by 5
Self-citationHulihan, M., Sayers, C. A., Grosse, S. D., Garrison, C., & Grant, A. M. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.09.020 · Cited by 5
A HAMP promoter bioassay system for identifying chemical compounds that modulate hepcidin expression
Kawabata, H., Uchiyama, T., Sakamoto, S., Kanda, J., Oishi, S., Fujii, N., Tomosugi, N., Kadowaki, N., & Takaori‐Kondo, A. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.01.005 · Cited by 5
Iron clad: iron homeostasis and the diagnosis of hereditary iron overload
Heeney, M. M. (2014) · Hematology · doi:10.1182/asheducation-2014.1.202 · Cited by 5
The Cellular Physiology of Iron
Anderson, G. J., & Vulpe, C. D. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_1 · Cited by 7
Hepcidin: looking back at two decades of progress
Ganz, T. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00034-8 · Cited by 5
A Revised Classification of Primary Iron Overload Syndromes
Tatsumi, Y., Yano, M., Wakusawa, S., Miyajima, H., Ishikawa, T., Imashuku, S., Takano, A., Nihei, W., Kato, A., Kato, K., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00290 · Cited by 5
“4 Neverthe-less, a small number of patients were affected not only by autosomal recessive HC associated with mutations in TFR2 , 5 HJV , 6 and HAMP , 7 but also by autosomal dominant ferropor-tin (FP) disease (FP-D) with mutant genes in SLC40A1 , 8,9 regardless of ethnicity.”
BackgroundMagens, B., Düllmann, J., Schümann, K., Wulfhekel, U., & Nielsen, P. (2005) · Acta Histochemica · doi:10.1016/j.acthis.2004.08.006 · Cited by 5
Estudio del paciente con hiperferritinemia
Campuzano‐Maya, G. (2017) · Medicina y Laboratorio · doi:10.36384/01232576.19 · Cited by 5
“En estos ca - sos se recomienda el estudio de gen HFE y otros estudios adicionales como los genes del receptor de l transferrina -2 ( TFR2 ) [167], la hepcidina ( HAMP ) [168] , la homojuveli - na ( HFE2 ) [169] y la ferroportina ( SLC40A1 ) [169] , entre otros.”
BackgroundWu, H., Liu, J., Yan, D., Li, L., Zhuang, X., Li, H., Zhou, Z., & Zhou, H. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1522 · Cited by 6
“, 2004), type 2B, mutation in the HAMP gene on chromosome 19 (Roetto et al., 2003), type 3, mutation of the transferrin receptor 2 gene (TFR2, OMIM: 604720) on chromosome 7 (Roetto et al.”
BackgroundNatural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases
Sheikh, N. W. A., Kosalge, S. B., Desai, T. R., Dewani, A. P., Mohale, D., & Tripathi, A. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98749 · Cited by 7
Tenenbein, M., & Huang, X. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822946-0.00016-7 · Cited by 5
[Iron metabolism, overview and recent insights].
Omar, S., Feki, M., & Kaabachi, N. (2006) · PubMed · Cited by 15
Troadec, M., Loréal, O., & Brissot, P. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)40611-9 · Cited by 5
Surcharges héréditaires en fer
Brissot, P., Bardou‐Jacquet, E., Latournerie, M., Ropert, M., Island, M., Loréal, O., & Jouanolle, A. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.10.011 · Cited by 6
MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T. J., McNeill, K., & Jerums, G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110976 · Cited by 5
Laboratory use of hepcidin in renal transplant recipients
Šimetić, L., & Zibar, L. (2016) · Biochemia Medica · doi:10.11613/bm.2016.003 · Cited by 5
“It physiologically prevents iron utilization and iron overload; his down-regulation was first documented in iron overload disorders most forms of hereditary hemochromatosis (16-19) and later in cases of thalassemia (20).”
BackgroundBoden, G. H., Scapa, E. F., Kanno, K., Cohen, D. E., Brosnan, M. E., Brosnan, J. T., Pessayre, D., Roy‐Chowdhury, N., Lu, Y., Roy‐Chowdhury, J., et al. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch2c · Cited by 9
Le métabolisme du fer chez l’homme
Gall, J. L., Jouanolle, A., Mosser, J., & David, V. (2005) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)33421-1 · Cited by 5
A Novel Ferroportin Disease in a Japanese Patient
Kohgo, Y. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.393 · Cited by 5
Hereditary hemochromatosis: Is the gene race over?
Gasparini, P., & Camaschella, C. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201176 · Cited by 5
Self-citationPietrangelo, A. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_10 · Cited by 4
Tao, Y., Chen, Y., Ren, J., Jiang, S., Zhang, S., Xu, H. G., & Li, Y. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741173 · Cited by 4
Role and regulation of iron metabolism in erythropoiesis and disease
Arvedson, T., & Sasu, B. J. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8698-6_15 · Cited by 4
“Mutations in the human hepcidin gene have been identified which result in juvenile onset hemochromatosis, a severe form of hereditary hemochromatosis resulting in extensive iron loading early in life [ 63 ].”
BackgroundPhysiologie und Pathophysiologie des Eisenstoffwechsels
Nielsen, P., & Gaedicke, G. (2005) · Springer eBooks · doi:10.1007/3-540-29036-2_7 · Cited by 5
Pelusi, S., Rametta, R., Corte, C. D., Congia, R., Dongiovanni, P., Pulixi, E. A., Fargion, S. R., Fracanzani, A. L., Nobili, V., & Valenti, L. V. C. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31259-1 · Cited by 4
Iron metabolism and diagnosis of iron overload disorders
Dever, J. B., & Kowdley, K. V. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050903440138 · Cited by 4
“Mutations in thehepcidin gene are associatedwith juvenile hemochromatosis [31].”
BackgroundAn ultrasensitive magnetoelectric sensor system for the quantitative detection of liver iron
Xi, H., Meng-Chien, L., Qian, X., Zhang, Q., Rupprecht, S., & Yang, Q. (2016) · Proceedings of IEEE Sensors/Proceedings of IEEE Sensors ... · doi:10.1109/icsens.2016.7808778 · Cited by 4
“The concentration and total amount of iron in different tissues are critical parameters that determine the clinical outcome in all forms of iron overload that can be caused by hereditary hemochromatosis, thalassemia intermedia, iron loading anemia, thalassemia major, sickle cell disease, aplastic anemia, and other pat…”
Pietrangelo, A., & Torbenson, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00004-2 · Cited by 7
Iron Deficiency, Iron Overload and Therapy
Crichton, R. R. (2016) · Wiley eBooks · doi:10.1002/9781118925645.ch11 · Cited by 4
Reichert, C. O., da Cunha, J., Levy, D., Maselli, L. M. F., Bydlowski, S. P., & Spada, C. (2017) · InTech eBooks · doi:10.5772/intechopen.69507 · Cited by 5
“A homozygous region with two mutations was identified (93delG e 166C → T) in two families that presented iron overload in the first decades of life, characterizing juvenile haemochromatosis type 2B [67].”
BackgroundIron Metabolism and Related Disorders
Ginzburg, Y. Z., & Finberg, K. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00012-1 · Cited by 4
Hepcidin: an emerging biomarker for iron disorders, inflammatory diseases, and infections
Westerman, M. E., Olbina, G., Ostland, V. E., Nemeth, E., & Ganz, T. (2010) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.854910 · Cited by 4
“The iron channel, ferroportin, is found in all the tissues that export iron into plasma: basolateral membranes of duodenal enterocytes and the cell membranes of placental cells, hepatocytes and macrophages (14).”
BackgroundOf mice and men: genetic determinants of iron status
McGregor, J., McKie, A. T., & Simpson, R. J. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2003312 · Cited by 5
“Indeed, as mentioned earlier, there has been a recent report of two hepcidin mutations in two unrelated probands with JH: a homozygous mutation in which a guanine base was deleted in exon 2 at nucleotide position 93 resulting in a frameshift, and a nonsense CfiT substitution at position 166 in exon 3 resulting in an R…”
BackgroundMilward, E. A., Trinder, D., Wilcox, C., Britton, R. S., Ramm, G. A., Olynyk, J. K., Jaeschke, H., Mullen, K. D., & Moradpour, D. (2005) · Hepatology · doi:10.1002/hep.20652 · Cited by 4
Lee, S.-M., Loguinov, A. V., Fleming, R. E., & Vulpe, C. D. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0443-1 · Cited by 4
“Other genetic factors could include another muta- tion in the HFE gene and/or mutations in genes known to be involved in iron metabolism causing non-HFE hemo- chromatosis (Whitfield et al. 2000; Lee et al. 2004; Roetto et al. 2003; Camaschella et al. 2000).”
BackgroundThe Central Role of the Liver in Iron Storage and Regulation of Systemic Iron Homeostasis
Rouault, T. A., Gordeuk, V. R., & Anderson, G. J. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch16 · Cited by 4
Molecular Regulation of Systemic Iron Metabolism
Ganz, T., & Vaulont, S. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_9 · Cited by 6
The bone of the liver (The hepcidin story contd)
Deugnier, Y. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2010.04.003 · Cited by 6
“[6] Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al.”
Surcharges en fer héréditaires non liées au gène HFE
Aguilar‐Martinez, P. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2007.01.042 · Cited by 5
Diagnostic d’une surcharge hépatique en fer
Deugnier, Y., Bardou‐Jacquet, E., Lainé, F., Gandon, Y., & Jouanolle, A. (2012) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.03.007 · Cited by 4
Actualités sur l’hémochromatose
Loréal, O., Lan, C. L., Troadec, M., Guyader, D., & Brissot, P. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)94993-7 · Cited by 4
“[58] de mutations homozygotes du gène de l’hepcidine chez des malades qui présentent une hémochromatose juvénile non liée à HFE.”
BackgroundEnns, C. A., Jue, S. F., & Zhang, A.-S. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111142 · Cited by 3
“Lack of hepcidin causes juvenile hemochromatosis, a severe iron overload disorder (5, 6), whereas inappropriately high levels of hepcidin result in iron-deficiency anemia (1, 2).”
Comparing the types of haemochromatosis- from genetics to clinics
Srinivasamurthy, P., & Mehta, K. J. (2026) · European Journal of Human Genetics · doi:10.1038/s41431-026-02084-z · Cited by 4
“This absence allows for unregulated, constant ferroportin expression and activity on cell surfaces, causing excessive iron export into the systemic circulation [4, 36, 37].”
Ferreira, J. T., Bicho, M., Faustino, P., & Serejo, F. (2025) · Viruses · doi:10.3390/v17101302 · Cited by 4
“On the other hand, the presence of inactivating mutations of hepcidin results in a rare form of juvenile hemochromatosis [80].”
Hémochromatose génétique : le rhumatologue en première ligne
Guggenbuhl, P., Coiffier, G., Chalès, G., Brissot, P., & Loréal, O. (2011) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2011.06.004 · Cited by 3
Treating iron overload with hepcidin
Camaschella, C. (2006) · Blood · doi:10.1182/blood-2006-01-0189 · Cited by 3
Self-citationSíndrome metabólico e inflamación
González, A. S., Bellido, D., Soto, M. B., Pértega-Díaz, S., del Olmo, M. M., & Vidal, O. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73667-1 · Cited by 3
Disorders of Epithelial Transport, Metabolism, and Digestion in the Small Intestine
Dalal, S. R., & Chang, E. B. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch65 · Cited by 3
A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines
Toki, Y., Sasaki, K., Tanaka, H., Yamamoto, M., Hatayama, M., Ito, S., Ikuta, K., Shindo, M., Hasebe, T., Nakajima, S., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.153 · Cited by 3
Deng, C., Vaulont, S., Mosser, J., Coppin, H., Roth, M., Kautz, L., Meynard, D., Monnier, A., Darnaud, V., Bouvet, R., et al. (2013) · Cited by 3
ДОНАЦІЇ КРОВІ І МЕТАБОЛІЗМ ЗАЛІЗА
Видиборець, С. В., & Дерпак, Ю. (2022) · Іnternational Science Group eBooks · doi:10.46299/979-8-88831-933-8 · Cited by 3
Iron metabolism: pathways and proteins in homeostasis
Arora, E. K., & Sharma, V. (2022) · Reviews in Inorganic Chemistry · doi:10.1515/revic-2022-0031 · Cited by 4
Iron Biology: Metabolism and Homeostasis
Ganz, T. (2022) · Nutrition and health · doi:10.1007/978-3-031-14521-6_2 · Cited by 4
Zoller, H. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_16 · Cited by 4
Iron therapy in patients with chronic kidney disease: taking the high road?
Hörl, W. H. (2009) · Cited by 3
Griffiths, W. J. (2011) · Medicine · doi:10.1016/j.mpmed.2011.07.004 · Cited by 3
Antimicrobial Peptides: Effectors of Innate Immunity
ZASLOFF, M. A. (2014) · ASM Press eBooks · doi:10.1128/9781555817671.ch17 · Cited by 3
Hemochromatosis and Iron Storage Disorders
Bacon, B. R., & Britton, R. S. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch30 · Cited by 3
Molecular Diagnosis of Genodermatoses
Wessagowit, V. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-227-8_3 · Cited by 3
Elisa Method For Serum Hepcidin Quantification In Bulgarian Population
Manolov, V., Atanasova, B. D., Vasilev, V. V., Tzatchev, K., & Velizarova, M. (2014) · Acta Medica Bulgarica · doi:10.2478/amb-2014-0003 · Cited by 6
“Evidence has emerged that in certain types of hereditary hemochromatosis, the cause of the disease is a defi ciency of hepcidin, resulting in unregulated uptake of iron and subsequent iron overload [2, 20].”
BackgroundRégulation de l'absorption du fer : données nouvelles
Cattan, D. (2004) · EMC - Hépatologie · doi:10.1016/j.emchep.2004.03.002 · Cited by 4
The Role of Hepcidin in Iron Homeostasis
Ganz, T. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_3 · Cited by 3
“, 2001), and its essential iron-regulatory role was established by the rapidly progressive iron overload of mice and humans with genetic hepcidin deficiency (Nicolas et al., 2001; Roetto et al., 2003), and the development of severe iron deficiency refractory to oral iron in mice and human overexpressing hepcidin (Nico…”
Background
Metadata
- Authors
- Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- National and Kapodistrian University of Athens (GR)
- University of Verona (IT)
- Theageneio General Hospital (GR)
- Corresponding author
- Camaschella, Clara
- ORCID
- Venue
- Nature Genetics
- Published
- 2002-12-09
- Volume
- 33
- Issue
- 1
- Pages
- 21-22
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2056282179
- Cited by
- 860
- References
- 16
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 13 · 2022: 14 · 2021: 25 · 2020: 23 · 2019: 14 · 2018: 19 · 2017: 35 · 2016: 23 · 2015: 32 · 2014: 28 · 2013: 37 · 2012: 37
- FWCI
- 32.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- hepcidin, juvenile hemochromatosis, antimicrobial peptides, iron absorption regulation, 19q13, hereditary hemochromatosis
- MeSH terms
- Amino Acid Sequence, Base Sequence, Child, DNA Mutational Analysis, Female, Hemochromatosis, Humans, Male, Molecular Sequence Data, Mutation, Pedigree, Polymorphism, Single-Stranded Conformational, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.